Home > PS Ratio > CAPLIN POINT LABORATORIES

CAPLIN POINT LABORATORIES
PS (Price/Sales) Ratio

The Current P/S Ratio of CAPLIN POINT LABORATORIES is 8.81.

Share Price ₹2,535.4Jul 03,2026
Market Cap ₹19,268.7 Cr
Sales-TTM₹2,187.2 CrTTM-Consolidated Results
Price/Sales8.81xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for CAPLIN POINT LABORATORIES
Please provide your vote to see the results
CAPLIN POINT LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of CAPLIN POINT LABORATORIES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of CAPLIN POINT LABORATORIES is calculated as :

Current Market Cap [ ₹19,268.7 Cr] as on Jul 03,2026

(/) Sales [ ₹2,187.2 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 8.81x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for CAPLIN POINT LABORATORIES , the investors are currently willing to pay '8.81 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of CAPLIN POINT LABORATORIES !

The chart below summarizes the trend in P/S Ratio of CAPLIN POINT LABORATORIES over the last five years.

Historical PS (Price/Sales) ratio chart of CAPLIN POINT LABORATORIES


PS Ratio Performance Analysis for CAPLIN POINT LABORATORIES

- CAPLIN POINT LABORATORIES 's latest p/e ratio is 8.81x.

- CAPLIN POINT LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 4.76x.

- CAPLIN POINT LABORATORIES 's operated at median p/e ratio of 4.06x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, CAPLIN POINT LABORATORIES 's p/e ratio peaked in Mar2025 at 7.86x.

- CAPLIN POINT LABORATORIES 's p/e ratio hit its five-year low in Mar2021 of 2.88x.


How does CAPLIN POINT LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
CAPLIN POINT LABORATORIES 2,187.28.8119,268.7
SUN PHARMACEUTICAL INDUSTRIES LTD58,462.07.82456,989.0
DIVIS LABORATORIES LTD10,560.017.00179,471.0
TORRENT PHARMACEUTICALS LTD13,980.011.54161,290.0
CIPLA LTD28,162.64.18117,820.0
DR REDDYS LABORATORIES LTD33,700.23.40114,730.0
MANKIND PHARMA LTD14,277.67.32104,535.0
LUPIN LTD27,958.04.05113,215.0
ZYDUS LIFESCIENCES LTD27,148.44.19113,815.0
AUROBINDO PHARMA LTD33,653.12.7793,217.0
LAURUS LABS LTD6,812.912.2383,293.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs CAPLIN POINT LABORATORIES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.77x
Max industry PS 17.00x
Median industry PS 7.32x
Average industry PS 7.57x



You may also like the below Video Courses